P53 expression is not only related to the number of tumor-infiltrating lymphocytes and chemotherapy efficacy in TNBC patients (55, 56), but also promotes tumorigenesis by inducing the systemic circulation of EGFR (57). This evidence concerns the gene EGFR and neoplasm.